$19.47
0.060.31%
At Close: -
$19.47
00.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Nurix Therapeutics
NRIXNASDAQ
Nurix Therapeutics (NASDAQ:NRIX) Stock, Insider Trading Activity
Nurix Therapeutics: Insider buying and selling updated today.
Institutional Shares Held
29.048M
Institutional Percentage Held
47.6%
| Jul 01, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 0 | $11.33 | -$109.12K | SELL-OPTIONS | 0.00% | 19.838K | Jul 01 | View |
| Jun 20, 2024 | Hans van Houte | CHIEF FINANCIAL OFFICER | -20K | $20.01 | -$400.22K | SELL | -29.27% | 48.333K | Jun 20 | View |
| Jun 13, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 0 | $9.44 | -$28.25K | SELL-OPTIONS | 0.00% | 19.838K | Jun 13 | View |
| Jun 12, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 0 | $9.44 | -$28.79K | SELL-OPTIONS | 0.00% | 19.838K | Jun 12 | View |
| Jun 05, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 0 | $9.43 | -$6.06K | SELL-OPTIONS | 0.00% | 19.838K | Jun 05 | View |
| Jun 03, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 0 | $9.44 | -$24.18K | SELL-OPTIONS | 0.00% | 19.838K | Jun 03 | View |
| May 02, 2024 | Hans van Houte | CHIEF FINANCIAL OFFICER | -3.499K | $12.83 | -$44.88K | SELL | -4.87% | 68.333K | May 02 | View |
| Apr 30, 2024 | Hans van Houte | CHIEF FINANCIAL OFFICER | 3.499K | $12.04 | -$16.70K | SELL-OPTIONS | 5.12% | 71.832K | Apr 30 | View |
| Apr 30, 2024 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 3.199K | $12.04 | -$24.17K | SELL-OPTIONS | 8.79% | 39.601K | Apr 30 | View |
| Apr 30, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 2.411K | $12.04 | -$18.22K | SELL-OPTIONS | 13.83% | 19.838K | Apr 30 | View |
| Feb 16, 2024 | Hans van Houte | CHIEF FINANCIAL OFFICER | -6.812K | $10.02 | -$68.22K | SELL | -9.07% | 68.333K | Feb 16 | View |
| Jan 30, 2024 | Hans van Houte | CHIEF FINANCIAL OFFICER | 3.215K | $7.99 | -$13.35K | SELL-OPTIONS | 4.47% | 75.145K | Jan 30 | View |
| Jan 30, 2024 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 2.873K | $7.99 | -$18.65K | SELL-OPTIONS | 8.57% | 36.402K | Jan 30 | View |
| Jan 30, 2024 | Christine Ring | CHIEF LEGAL OFFICER | 2.164K | $7.99 | -$14.06K | SELL-OPTIONS | 14.18% | 17.427K | Jan 30 | View |
| Dec 21, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | -3.541K | $10.00 | -$35.42K | SELL | -4.69% | 71.93K | Dec 20 | View |
| Dec 20, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | -10.906K | $10.00 | -$109.09K | SELL | -12.63% | 75.471K | Dec 19 | View |
| Nov 01, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 3.806K | $5.20 | -$5.61K | SELL-OPTIONS | 4.61% | 86.377K | Oct 30 - Oct 31 | View |
| Nov 01, 2023 | Christine Ring | CHIEF LEGAL OFFICER | 2.692K | $5.20 | -$6.40K | SELL-OPTIONS | 21.41% | 15.263K | Oct 30 - Oct 31 | View |
| Nov 01, 2023 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 3.574K | $5.20 | -$8.49K | SELL-OPTIONS | 11.93% | 33.529K | Oct 30 - Oct 31 | View |
| Aug 01, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 3.641K | $9.65 | -$12.02K | SELL-OPTIONS | 4.61% | 82.571K | Jul 30 - Jul 31 | View |
| Aug 01, 2023 | Christine Ring | GENERAL COUNSEL | 2.504K | $9.65 | -$13.71K | SELL-OPTIONS | 24.94% | 12.544K | Jul 30 - Jul 31 | View |
| Aug 01, 2023 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 3.323K | $9.65 | -$18.19K | SELL-OPTIONS | 12.48% | 29.955K | Jul 30 - Jul 31 | View |
| May 02, 2023 | Stefani Wolff | EVP AND COO | 620 | $9.88 | -$3.38K | SELL-OPTIONS | 11.29% | 6.113K | Apr 30 - May 01 | View |
| May 02, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 2.165K | $9.88 | -$7.12K | SELL-OPTIONS | 2.82% | 78.93K | Apr 30 - May 01 | View |
| May 02, 2023 | Christine Ring | GENERAL COUNSEL | 1.242K | $9.88 | -$6.74K | SELL-OPTIONS | 14.12% | 10.04K | Apr 30 - May 01 | View |
| May 02, 2023 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 2.07K | $9.88 | -$11.22K | SELL-OPTIONS | 8.43% | 26.632K | Apr 30 - May 01 | View |
| Feb 01, 2023 | Stefani Wolff | EVP AND COO | 538 | $11.78 | -$4.99K | SELL-OPTIONS | 15.81% | 3.94K | Jan 30 | View |
| Feb 01, 2023 | Hans van Houte | CHIEF FINANCIAL OFFICER | 1.962K | $11.78 | -$10.88K | SELL-OPTIONS | 2.62% | 76.765K | Jan 30 | View |
| Feb 01, 2023 | Christine Ring | GENERAL COUNSEL | 1.076K | $11.78 | -$9.99K | SELL-OPTIONS | 17.40% | 7.261K | Jan 30 | View |
| Feb 01, 2023 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 1.795K | $11.78 | -$16.63K | SELL-OPTIONS | 8.46% | 23.009K | Jan 30 | View |
| Nov 01, 2022 | Hans van Houte | CHIEF FINANCIAL OFFICER | 2.147K | $12.88 | -$9.52K | SELL-OPTIONS | 2.96% | 74.803K | Oct 30 - Oct 31 | View |
| Nov 01, 2022 | Christine Ring | GENERAL COUNSEL | 1.225K | $12.88 | -$9.00K | SELL-OPTIONS | 24.70% | 6.185K | Oct 30 - Oct 31 | View |
| Nov 01, 2022 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 2.042K | $12.88 | -$15.01K | SELL-OPTIONS | 10.65% | 21.214K | Oct 30 - Oct 31 | View |
| Nov 01, 2022 | Stefani Wolff | EVP AND COO | 612 | $12.88 | -$4.51K | SELL-OPTIONS | 21.94% | 3.402K | Oct 30 - Oct 31 | View |
| Aug 02, 2022 | Christine Ring | GENERAL COUNSEL | 1.212K | $15.67 | -$11.16K | SELL-OPTIONS | 35.62% | 4.615K | Jul 30 - Aug 01 | View |
| Aug 02, 2022 | Stefani Wolff | EVP AND COO | 606 | $15.67 | -$5.58K | SELL-OPTIONS | 95.89% | 1.238K | Jul 30 - Aug 01 | View |
| Aug 02, 2022 | Hans van Houte | CHIEF FINANCIAL OFFICER | 2.134K | $15.67 | -$11.78K | SELL-OPTIONS | 3.03% | 72.656K | Jul 30 - Aug 01 | View |
| Aug 02, 2022 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 2.021K | $15.67 | -$18.58K | SELL-OPTIONS | 11.78% | 19.172K | Jul 30 - Aug 01 | View |
| May 03, 2022 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 2.108K | $11.75 | -$12.90K | SELL-OPTIONS | 14.01% | 17.151K | Apr 30 - May 02 | View |
| May 03, 2022 | Stefani Wolff | EVP AND COO | 632 | $11.75 | -$3.88K | SELL-OPTIONS | ∞ | 632 | Apr 30 - May 02 | View |
| May 03, 2022 | Hans van Houte | CHIEF FINANCIAL OFFICER | 2.189K | $11.75 | -$8.19K | SELL-OPTIONS | ∞ | 2.189K | Apr 30 - May 02 | View |
| May 03, 2022 | Christine Ring | GENERAL COUNSEL | 1.264K | $11.75 | -$7.75K | SELL-OPTIONS | 59.09% | 3.403K | Apr 30 - May 02 | View |
| Jan 11, 2022 | Christine Ring | GENERAL COUNSEL | 0 | $14.50 | -$30.34K | SELL-OPTIONS | 0.00% | 1.286K | Jan 10 | View |
| Jan 04, 2022 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $19.01 | -$36.37K | SELL-OPTIONS | 0.00% | 14.197K | Jan 03 | View |
| Dec 13, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $15.45 | -$32.62K | SELL-OPTIONS | 0.00% | 1.286K | Dec 10 | View |
| Dec 02, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $18.20 | -$8.75K | SELL-OPTIONS | 0.00% | 14.197K | Dec 01 | View |
| Nov 12, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $17.12 | -$36.62K | SELL-OPTIONS | 0.00% | 1.286K | Nov 10 | View |
| Nov 02, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $20.25 | -$10.39K | SELL-OPTIONS | 0.00% | 14.197K | Nov 01 | View |
| Oct 28, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $18.55 | -$26.71K | SELL-OPTIONS | 0.00% | 1.286K | Oct 27 | View |
| Oct 28, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $21.13 | -$11.10K | SELL-OPTIONS | 0.00% | 14.197K | Oct 27 | View |
| Oct 12, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $14.61 | -$30.60K | SELL-OPTIONS | 0.00% | 1.286K | Oct 11 | View |
| Oct 04, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $18.59 | -$9.06K | SELL-OPTIONS | 0.00% | 14.197K | Oct 01 | View |
| Sep 13, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $18.90 | -$68.14K | SELL-OPTIONS | 0.00% | 1.286K | Sep 10 | View |
| Sep 08, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $18.55 | -$106.85K | SELL-OPTIONS | 0.00% | 1.286K | Sep 07 | View |
| Sep 08, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $21.13 | -$44.38K | SELL-OPTIONS | 0.00% | 14.197K | Sep 07 | View |
| Sep 02, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $19.80 | -$10.03K | SELL-OPTIONS | 0.00% | 14.197K | Sep 01 | View |
| Aug 11, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $15.87 | -$33.61K | SELL-OPTIONS | 0.00% | 805 | Aug 10 | View |
| Aug 11, 2021 | Pierre Beaurang | CHIEF BUSINESS OFFICER | 0 | $15.48 | -$215.60K | SELL-OPTIONS | 0.00% | 120.996K | Aug 10 | View |
| Aug 03, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $19.23 | -$9.58K | SELL-OPTIONS | 0.00% | 13.804K | Aug 02 | View |
| Jul 21, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $14.43 | -$30.17K | SELL-OPTIONS | 0.00% | 805 | Jul 20 | View |
| Jul 12, 2021 | Pierre Beaurang | CHIEF BUSINESS OFFICER | 0 | $12.52 | -$171.09K | SELL-OPTIONS | 0.00% | 120.996K | Jul 12 | View |
| Jul 02, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $17.01 | -$7.80K | SELL-OPTIONS | 0.00% | 13.804K | Jul 01 | View |
| Jun 11, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $15.63 | -$33.05K | SELL-OPTIONS | 0.00% | 805 | Jun 10 | View |
| Jun 11, 2021 | Pierre Beaurang | CHIEF BUSINESS OFFICER | 0 | $15.24 | -$211.92K | SELL-OPTIONS | 0.00% | 120.996K | Jun 10 | View |
| Jun 02, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $17.50 | -$8.19K | SELL-OPTIONS | 0.00% | 13.804K | Jun 01 | View |
| May 11, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $14.43 | -$30.17K | SELL-OPTIONS | 0.00% | 805 | May 10 | View |
| May 11, 2021 | Pierre Beaurang | CHIEF BUSINESS OFFICER | 0 | $13.80 | -$190.32K | SELL-OPTIONS | 0.00% | 120.996K | May 10 | View |
| May 04, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $21.13 | -$22.19K | SELL-OPTIONS | 0.00% | 13.804K | May 03 | View |
| Apr 29, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $18.55 | -$26.71K | SELL-OPTIONS | 0.00% | 805 | Apr 28 | View |
| Apr 13, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $14.53 | -$30.41K | SELL-OPTIONS | 0.00% | 805 | Apr 12 | View |
| Apr 13, 2021 | Pierre Beaurang | CHIEF BUSINESS OFFICER | 0 | $14.15 | -$196.95K | SELL-OPTIONS | 0.00% | 120.996K | Apr 12 | View |
| Apr 06, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $21.13 | -$11.10K | SELL-OPTIONS | 0.00% | 13.804K | Apr 05 | View |
| Apr 02, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $19.41 | -$9.72K | SELL-OPTIONS | 0.00% | 13.804K | Apr 01 | View |
| Mar 16, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $26.13 | -$30.19K | SELL-OPTIONS | 0.00% | 13.804K | Mar 16 | View |
| Mar 11, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $21.56 | -$78.82K | SELL-OPTIONS | 0.00% | 805 | Mar 10 | View |
| Mar 09, 2021 | Pierre Beaurang | CHIEF BUSINESS OFFICER | 0 | $18.93 | -$271.38K | SELL-OPTIONS | 0.00% | 116.666K | Mar 08 | View |
| Mar 02, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $21.61 | -$22.95K | SELL-OPTIONS | 0.00% | 13.804K | Mar 01 | View |
| Feb 25, 2021 | Hans van Houte | CHIEF FINANCIAL OFFICER | 0 | $20.83 | -$1.35M | SELL-OPTIONS | 0.00% | 0 | Feb 24 | View |
| Feb 23, 2021 | Hans van Houte | CHIEF FINANCIAL OFFICER | 0 | $20.52 | -$206.95K | SELL-OPTIONS | 0.00% | 0 | Feb 22 | View |
| Feb 22, 2021 | Hans van Houte | CHIEF FINANCIAL OFFICER | 0 | $18.15 | -$470.21K | SELL-OPTIONS | 0.00% | 0 | Feb 18 | View |
| Feb 22, 2021 | Christine Ring | GENERAL COUNSEL | 0 | $18.87 | -$68.03K | SELL-OPTIONS | 0.00% | 0 | Feb 18 | View |
| Feb 22, 2021 | Gwenn Hansen | CHIEF SCIENTIFIC OFFICER | 0 | $21.77 | -$23.21K | SELL-OPTIONS | 0.00% | 12K | Feb 18 | View |
| Feb 22, 2021 | Pierre Beaurang | CHIEF BUSINESS OFFICER | 0 | $19.59 | -$477.08K | SELL-OPTIONS | 0.00% | 0 | Feb 18 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
NRIX Insider Trading News
No news found